logo 胸外文献每日监控
2026年8月13日星期四
← 返回 全部文献

食管癌新辅助化疗免疫治疗后临床完全缓解的内镜组织学验证

Endoscopic histological validation of clinical complete response after neoadjuvant chemoimmunotherapy for esophageal cancer.

期刊
Endoscopy
PMID
42537657
原文
PubMed ↗
发布日期

作者

  • Shuai Tian — Chinese PLA General Hospital First Medical Center, Department of Gastroenterology, Beijing, China, Beijing.
  • Zhikuan Wang — The Fifth Medical Center of Chinese PLA General Hospital, Department of Oncology, China, Beijing.
  • Xinye Zuo — Chinese PLA General Hospital First Medical Center, Department of Gastroenterology, Beijing, China, Beijing.
  • Qun Shao — Chinese PLA General Hospital First Medical Center, Department of Gastroenterology, Beijing, China, Beijing.
  • Enqiang Linghu — Chinese PLA General Hospital First Medical Center, Department of Gastroenterology, Beijing, China, Beijing.
  • Qianqian Chen — Chinese PLA General Hospital First Medical Center, Department of Gastroenterology, Beijing, China, Beijing.

作者单位

  • Chinese PLA General Hospital First Medical Center, Department of Gastroenterology, Beijing, China, Beijing.
  • The Fifth Medical Center of Chinese PLA General Hospital, Department of Oncology, China, Beijing.

摘要

中文

(暂无中文翻译)

English

(no abstract)

分类与指标

研究类型
临床研究
病种
食管癌
JCR 分区
Q1
影响因子
11.8
新锐分区
1区